Adipose Tissue as a Strategic Source of Mesenchymal Stem Cells in Bone Regeneration: A Topical Review on the Most Promising Craniomaxillofacial Applications.
Francesco PaduanoMassimo MarrelliMassimiliano AmanteaCarlo RengoSandro RengoMichel GoldbergGianrico SpagnuoloMarco TatulloPublished in: International journal of molecular sciences (2017)
Bone regeneration in craniomaxillofacial surgery represents an issue that involves both surgical and aesthetic aspects. The most recent studies on bone tissue engineering involving adipose-derived stromal/stem cells (ASCs) have clearly demonstrated that such cells can play a crucial role in the treatment of craniomaxillofacial defects, given their strong commitment towards the osteogenic phenotype. A deeper knowledge of the molecular mechanisms underlying ASCs is crucial for a correct understanding of the potentialities of ASCs-based therapies in the most complex maxillofacial applications. In this topical review, we analyzed the molecular mechanisms of ASCs related to their support toward angiogenesis and osteogenesis, during bone regeneration. Moreover, we analyzed both case reports and clinical trials reporting the most promising clinical applications of ASCs in the treatment of craniomaxillofacial defects. Our study aimed to report the main molecular and clinical features shown by ASCs, used as a therapeutic support in bone engineering, as compared to the use of conventional autologous and allogeneic bone grafts.
Keyphrases
- bone regeneration
- bone marrow
- mesenchymal stem cells
- stem cells
- adipose tissue
- clinical trial
- minimally invasive
- emergency department
- healthcare
- stem cell transplantation
- endothelial cells
- low dose
- randomized controlled trial
- cell death
- vascular endothelial growth factor
- adverse drug
- combination therapy
- open label
- body composition
- drug induced
- study protocol
- high dose
- replacement therapy
- double blind
- acute coronary syndrome
- platelet rich plasma
- phase ii
- case control
- soft tissue